Literature DB >> 22027319

Comparison of clinically relevant technical attributes of five insulin injection pens.

Toshinari Asakura1.   

Abstract

BACKGROUND: Insulin injection pens are the predominant devices for insulin delivery in Europe and Japan because of their ease of use and convenience. This study compared clinically relevant technical attributes of durable insulin pens that are important to people with diabetes, specifically functions relating to cartridge-fitting, dose-setting, and dose-delivery on NovoPen® 4, ClikStar®, HumaPen Luxura®, Itango®, and Biosulin® Pen.
METHODS: Frequency components and duration of audible clicks on dose setting and injection were measured using audio equipment when setting and delivering 20 IU of insulin. To assess cartridge-fitting torque, each pen was attached to a torque gauge via the attached needle, and torque was measured with each 180° turn as the cartridge was screwed into the body of the pen. Rotary torque of the dose-setting dial was measured when setting the dose to the maximum dose unit of the pen. Injection force was measured when delivering 20 IU at 5 mm/s in a vertical position and at a tilt of 14.7° from vertical.
RESULTS: Audible clicks on dose-setting and dose-delivery were most distinguishable on NovoPen 4, while NovoPen 4 and ClikStar had generally lower cartridge-fitting torque and injection (both vertical and angled) force values.
CONCLUSION: Overall, the results showed that durable insulin pens such as NovoPen 4 have useful features related to assembly, dose-setting, and injection, which may facilitate ease of use for diabetes patients, particularly elderly patients and those with visual and/or manual dexterity impairments.
© 2011 Diabetes Technology Society.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22027319      PMCID: PMC3208882          DOI: 10.1177/193229681100500527

Source DB:  PubMed          Journal:  J Diabetes Sci Technol        ISSN: 1932-2968


  11 in total

Review 1.  Diabetic autonomic neuropathy.

Authors:  Aaron I Vinik; Raelene E Maser; Braxton D Mitchell; Roy Freeman
Journal:  Diabetes Care       Date:  2003-05       Impact factor: 19.112

2.  Quality of life, treatment satisfaction, and treatment preference associated with use of a pen device delivering a premixed 70/30 insulin aspart suspension (aspart protamine suspension/soluble aspart) versus alternative treatment strategies.

Authors:  Richard R Rubin; Mark Peyrot
Journal:  Diabetes Care       Date:  2004-10       Impact factor: 19.112

3.  Compliance and administration methods in management of type 1 diabetes.

Authors:  Fortunato Lombardo; G Salzano; Maria Francesca Messina; Filippo De Luca
Journal:  Acta Biomed       Date:  2005

Review 4.  Insulin delivery using pen devices. Simple-to-use tools may help young and old alike.

Authors:  N J Bohannon
Journal:  Postgrad Med       Date:  1999-10-15       Impact factor: 3.840

5.  Preference for insulin delivery systems among current insulin users and nonusers.

Authors:  Kent H Summers; Sheryl L Szeinbach; Sheila M Lenox
Journal:  Clin Ther       Date:  2004-09       Impact factor: 3.393

6.  Effect of patient-selected intensive insulin therapy on quality of life.

Authors:  E Chantelau; T Schiffers; J Schütze; B Hansen
Journal:  Patient Educ Couns       Date:  1997-02

7.  Prevalence of distal diabetic polyneuropathy using quantitative sensory methods in a population with diabetes of more than 10 years' disease duration.

Authors:  José M Miralles-García; Pedro de Pablos-Velasco; Lucio Cabrerizo; María Pérez; Vanessa López-Gómez
Journal:  Endocrinol Nutr       Date:  2010-07-16

8.  Assessment of quality of treatment in insulin-treated patients with diabetes using a pre-filled insulin pen. The ORBITER Study Group.

Authors:  Stefano Albano
Journal:  Acta Biomed       Date:  2004-04

9.  Accuracy and precision of low-dose insulin administration using syringes, pen injectors, and a pump.

Authors:  Katherine Keith; David Nicholson; Douglas Rogers
Journal:  Clin Pediatr (Phila)       Date:  2004 Jan-Feb       Impact factor: 1.168

10.  Comparison of NovoPen 3 and syringes/vials in the acceptance of insulin therapy in NIDDM patients with secondary failure to oral hypoglycaemic agents.

Authors:  A Kadiri; A Chraibi; F Marouan; M R Ababou; N el Guermai; A Wadjinny; A Kerfati; M Douiri; J D Bensouda; J Belkhadir; Y Arvanitis
Journal:  Diabetes Res Clin Pract       Date:  1998-07       Impact factor: 5.602

View more
  5 in total

1.  Functional Evaluation of the Reusable JuniorSTAR® Half-Unit Insulin Pen.

Authors:  David Klonoff; Irina Nayberg; Ivana Rabbone; Catherine Domenger; Udo Stauder; Hamid Oualali; Thomas Danne
Journal:  J Diabetes Sci Technol       Date:  2015-01-28

Review 2.  Half-Unit Insulin Pens: Disease Management in Patients With Diabetes Who Are Sensitive to Insulin.

Authors:  David C Klonoff; Irina Nayberg; Udo Stauder; Hamid Oualali; Catherine Domenger
Journal:  J Diabetes Sci Technol       Date:  2016-11-28

3.  Analysis: desirable attributes of insulin injection pens that drive patient preference and compliance.

Authors:  Jeffrey D Zahn
Journal:  J Diabetes Sci Technol       Date:  2011-09-01

4.  Dialing torque preferences of people with diabetes when using insulin pens: a pilot study.

Authors:  Arnd Friedrichs; Mario Schmitz; Stefan Kamlot; Steffen Adler
Journal:  Diabetes Ther       Date:  2015-01-27       Impact factor: 2.945

Review 5.  NovoPen Echo(®) insulin delivery device.

Authors:  Jacob Hyllested-Winge; Thomas Sparre; Line Kynemund Pedersen
Journal:  Med Devices (Auckl)       Date:  2016-01-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.